"
Team:Alberta/Project/Recombineering
From 2009.igem.org
 |
|
|
What is Recombineering?Recombineering refers to the strategic use of recombination in vivo in order to reach a defined goal. In the case of BioBytes, a method is required to target the final construct for insertion at a specific place on the E. coli chromosome. To do this successfully, three components must be taken into account:
|
TargetingWe have chosen to employ the Red Recombination System from bacteriophage lambda. Lambda Red recombinase causes specific crossover events between the ends of a linear and homologous chromosomal DNA. If the ends of a fragment contain at least 50 bp of homology to two separate sites on the E. coli chromosome, the genetic material between these two homologous regions will be exchanged. This provides the basis for our chromosome assembly system. Figure 1. 
The homologous regions must be a minimum of 50 base pairs in length for recombination to occur at a significant frequency. These homologous regions can be produced in different ways:
|
Inducible Recombination SystemThe lambda Red recombinase system consists primarily of three proteins: lambda exonuclease, which progressively removes 5' nucleotides from linear dsDNA; beta protein, which binds to ssDNA and promotes strand annealing; and gamma protein, which binds to the bacterial RecBCD enzyme to inhibit its activity. These three genes are contained on the plasmid pKD46 downstream from an arabinose promoter. For further regulation, this plasmid contains the RepA temperature sensitive origin. Therefore, one can induce chromosomal integration of a transformed linear DNA fragment with arabinose induction, then cure the cell of the pKD46 plasmid with growth at 42°C. This system leaves a host cell with a specific chromosomal mutation, and free of lambda Red recombinase in order to prevent future random, unwanted recombination within the cell. |
Our Efforts at RecombineeringAttempt I: Our first attempt at recombineering entailed the integration of an ampicillin resistance cassette into a non-coding, non-regulatory region of the host chromosome. AmpR cassette primers were engineered with 50 bp extensions that were homologous to flanking portions of the region of the chromosome to be excised. The linear construct produced through PCR amplification with these primers was then electroporated into cells containing pKD46 that were pre-induced with arabinose. Cells were left to incubate at 30°C for four hours, then plated under selection for ampicillin resistance. Colonies with the intended recombination event were screened for using PCR. PCR amplification across the expected integration region was expected to produce markedly different fragment sizes between wildtype and ampicillin-resistant cells if integration of the AmpR cassette occurred. PCR verification showed no difference in fragment size between wildtype and ampicillin-resistant cells. This led us to believe that non-specific recombination occurred and that the 50 bp of homology used was not great enough for site-specific recombination using this method.
Attempt II: In order to decrease the degree of non-specific recombination, we attempted to integrate a linear construct with whole-gene homology into the chromosome. To do this, we flanked a chloramphenicol resistance cassette with an essential gene on either side. The region that would be excised during integration contained no known essential genes. The construct was built from five bytes using the BioBytes assembly method Figure 2.  The gel-purified construct was electroporated into cells containing pKD46 that were pre-induced with arabinose. Cells were left to incubate at 30°C for four hours, then plated under selection for chloramphenicol resistance. However, no colonies grew. This indicated either that recombination did not occur, or that the cassette was non-functional. We did not have time for further troubleshooting. |
